Superworth

Amarin Corp Plc EPS AMRN

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.07
Latest quarter, Q2 FY26
−$0.02
Fiscal year 2025
−$0.09

Amarin Corp Plc's earnings per share was −$0.07 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.02.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.09n/a
FY2024−$4.00n/a
FY2023−$2.80n/a
FY2022−$5.40−1000%
FY2021$0.60n/a
FY2020−$1.20n/a
FY2019−$1.40n/a
FY2018−$7.80n/a
FY2017−$5.00n/a
FY2016−$8.20n/a
FY2015−$16.60n/a
FY2014−$7.00n/a
FY2013−$23.00n/a
FY2011−$14.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.02n/a−$0.07
Q1 FY26−$0.03n/a−$0.08
Q4 FY25$0.00n/a−$0.09
Q3 FY25−$0.02n/a−$2.49
Q2 FY25−$0.03n/a−$3.67
Q1 FY25−$0.04n/a−$3.64
Q4 FY24−$2.40n/a−$4.00
Q3 FY24−$1.20n/a−$1.80
Q2 FY24$0.00n/a−$1.60
Q1 FY24−$0.40n/a−$2.40
Q4 FY23−$0.20n/a−$2.80
Q3 FY23−$1.00n/a−$2.60

Against its peers

Companies in Drug Manufacturers - General nearest Amarin Corp Plc's size, closest first, today.

CompanyEPS, 12 monthsGrowth
AMRNAmarin Corp Plc−$0.07
NATRNatures Sunshine Products$1.01+36% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
ABUSArbutus Biopharma$0.78
LFVNLifevantage$0.40−46% a year
SPROSpero Therapeutics$0.11
Peer median$0.78

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Amarin Corp Plc

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.